XXII - Spark Newswire

3 minute read

Chart: How Have Cannabis Industry Sectors Performed This Year And What Are Their Valuation Multiples? Do They Make Sense?

Today, 8:35 PM

Viridian Capital Advisors breaks the cannabis industry down into 12 sub sectors for purposes of tracking capital raises, M&A activity, valuation, and credit analysis by industry sector.

ARNA

9 minute read

The Week In Cannabis: Canopy’s Earnings, JPMorgan’s Restrictions, A Slew Of Earnings, Big Policy Moves

By Javier Hasse

Today, 8:35 PM

Below is a recap of the main news related to the cannabis industry and markets for the week of November 1st, 2021. Contents

AFCG

2 minute read

22nd Century Group Reports Revenue Gains In Q3, Seeks To Monetize Its Hemp & Cannabis Plant Lines

By Jelena Martinovic

Today, 8:35 PM

Plant-based biotech company 22nd Century Group, Inc. (NASDAQ: XXII) reported its results on Thursday for the third quarter ended September 30, revealing net sales of $7.8 million for the period, up 6.9% from the prior year's period.

ACB

1 minute read

Analyst Lowers Price Targets On These Leading Stocks; $TLRY Enters Spirits Market – Cannabis Daily, November 4, 2021

By Asli Tolon Coskun

Today, 8:35 PM

Start The Day With The Best Daily Pre-Market Overview Of The Cannabis Space Cantor Fitzgerald releases notes on several major cannabis companies: Green Thumb Industries(OTCQX: GTBIF)

AUSAF

1 minute read

22nd Century Group Q3 EPS $(0.06) Misses $(0.04) Estimate, Sales $7.81M Miss $8.15M Estimate

By Benzinga Newsdesk

Today, 8:35 PM

22nd Century Group (AMEX:XXII) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.04) by 50 percent. This is a 100 percent decrease over losses of $(0.03) per share from the

XXII

32 minute read

Earnings Scheduled For November 4, 2021

By Benzinga Insights

Today, 8:35 PM

Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.

AAOI

4 minute read

FDA
News

22nd Century Group VP Of Regulatory Science To Participate In FDLI Panel In Response To Recent FDA Action On Comprehensive Plan And Reduced Nicotine Mandate

By Benzinga Newsdesk

Today, 8:35 PM

22nd Century Group, Inc. (NASDAQ:XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and health and wellness through plant science, announced today that the

XXII